GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Bausch Health Companies Inc (NYSE:BHC) » Definitions » Cyclically Adjusted Price-to-FCF

Bausch Health (Bausch Health) Cyclically Adjusted Price-to-FCF : 2.19 (As of Apr. 27, 2024)


View and export this data going back to 1994. Start your Free Trial

What is Bausch Health Cyclically Adjusted Price-to-FCF?

As of today (2024-04-27), Bausch Health's current share price is $8.71. Bausch Health's Cyclically Adjusted FCF per Share for the quarter that ended in Dec. 2023 was $3.98. Bausch Health's Cyclically Adjusted Price-to-FCF for today is 2.19.

The historical rank and industry rank for Bausch Health's Cyclically Adjusted Price-to-FCF or its related term are showing as below:

BHC' s Cyclically Adjusted Price-to-FCF Range Over the Past 10 Years
Min: 1.07   Med: 6.92   Max: 118.91
Current: 2.26

During the past years, Bausch Health's highest Cyclically Adjusted Price-to-FCF was 118.91. The lowest was 1.07. And the median was 6.92.

BHC's Cyclically Adjusted Price-to-FCF is ranked better than
98.15% of 324 companies
in the Drug Manufacturers industry
Industry Median: 32.655 vs BHC: 2.26

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

Bausch Health's adjusted free cash flow per share data for the three months ended in Dec. 2023 was $0.672. Add all the adjusted free cash flow per share for the past 10 years together and divide 10 will get our Cyclically Adjusted FCF per Share, which is $3.98 for the trailing ten years ended in Dec. 2023.

Shiller PE for Stocks: The True Measure of Stock Valuation


Bausch Health Cyclically Adjusted Price-to-FCF Historical Data

The historical data trend for Bausch Health's Cyclically Adjusted Price-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bausch Health Cyclically Adjusted Price-to-FCF Chart

Bausch Health Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted Price-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only 8.50 5.53 6.49 1.65 2.01

Bausch Health Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Cyclically Adjusted Price-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.65 2.12 2.04 2.13 2.01

Competitive Comparison of Bausch Health's Cyclically Adjusted Price-to-FCF

For the Drug Manufacturers - Specialty & Generic subindustry, Bausch Health's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Bausch Health's Cyclically Adjusted Price-to-FCF Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Bausch Health's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Bausch Health's Cyclically Adjusted Price-to-FCF falls into.



Bausch Health Cyclically Adjusted Price-to-FCF Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted Price-to-FCF takes the Free Cash Flow per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/FCF calculation. Because it considers this 10-year average, it's often referred to as the CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF.

Bausch Health's Cyclically Adjusted Price-to-FCF for today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/ Cyclically Adjusted FCF per Share
=8.71/3.98
=2.19

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bausch Health's Cyclically Adjusted FCF per Share for the quarter that ended in Dec. 2023 is calculated as:

For example, Bausch Health's adjusted Free Cash Flow per Share data for the three months ended in Dec. 2023 was:

Adj_FreeCashFlowPerShare=Free Cash Flow per Share/CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=0.672/125.4675*125.4675
=0.672

Current CPI (Dec. 2023) = 125.4675.

Bausch Health Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201403 1.210 98.604 1.540
201406 0.739 99.473 0.932
201409 1.479 99.394 1.867
201412 1.987 98.367 2.534
201503 1.096 99.789 1.378
201506 1.029 100.500 1.285
201509 1.952 100.421 2.439
201512 1.481 99.947 1.859
201603 1.415 101.054 1.757
201606 1.099 102.002 1.352
201609 1.371 101.765 1.690
201612 1.287 101.449 1.592
201703 2.240 102.634 2.738
201706 0.631 103.029 0.768
201709 1.255 103.345 1.524
201712 1.433 103.345 1.740
201803 1.115 105.004 1.332
201806 0.373 105.557 0.443
201809 1.391 105.636 1.652
201812 0.725 105.399 0.863
201903 1.042 106.979 1.222
201906 0.784 107.690 0.913
201909 1.226 107.611 1.429
201912 0.422 107.769 0.491
202003 0.535 107.927 0.622
202006 0.363 108.401 0.420
202009 0.486 108.164 0.564
202012 0.871 108.559 1.007
202103 1.051 110.298 1.196
202106 1.102 111.720 1.238
202109 1.549 112.905 1.721
202112 0.067 113.774 0.074
202203 -0.333 117.646 -0.355
202206 0.185 120.806 0.192
202209 -3.638 120.648 -3.783
202212 1.045 120.964 1.084
202303 0.284 122.702 0.290
202306 0.477 124.203 0.482
202309 0.646 125.230 0.647
202312 0.672 125.468 0.672

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Bausch Health  (NYSE:BHC) Cyclically Adjusted Price-to-FCF Explanation

Compared with the regular Price-to-Free-Cash-Flow, which works poorly for cyclical businesses, the Cyclically Adjusted Price-to-FCF smoothed out the fluctuations of free cash flow during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted Price-to-FCF should give similar results to regular Price-to-Free-Cash-Flow.


Bausch Health Cyclically Adjusted Price-to-FCF Related Terms

Thank you for viewing the detailed overview of Bausch Health's Cyclically Adjusted Price-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Bausch Health (Bausch Health) Business Description

Traded in Other Exchanges
Address
2150 Saint Elzear Boulvard West, Laval, QC, CAN, H7L 4A8
Bausch Health Companies Inc is a global specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the dermatology, gastrointestinal, and ophthalmology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum revenue from the Bausch + Lomb segment.
Executives
Seana Carson officer: EVP, General Counsel 400 SOMERSET CORPORATE BLVD, BRIDGEWATER NJ 08807
John S Barresi officer: SVP, Controller & CAO 727 FIFTH AVENUE, NEW YORK NY 10022
Richard Mulligan director C/O ICAHN CAPITAL LP, 767 FIFTH AVENUE, SUITE 4700, NEW YORK NY 10153
Tom George Vadaketh officer: EVP, Chief Financial Officer 1727 JOCKEYS WAY, YARDLEY PA 19067
Robert Spurr director, officer: U.S. President-Pharma Business C/O BAUSCH HEALTH COMPANIES INC., 400 SOMERSET CORPORATE BLVD., BRIDGEWATER NJ 08807
Joseph F Gordon officer: Pres&Co-Head Bausch&Lomb/Int'l C/O BLCO, 400 SOMERSET CORPORATE BLVD., BRIDGEWATER NJ 08807
Frederick Munsch officer: SVP, Controller and CAO C/O BLCO, 400 SOMERSET CORPORATE BLVD., BRIDGEWATER NJ 08807
Christina Ackermann officer: EVP AND GENERAL COUNSEL C/O BLCO, 400 SOMERSET CORPORATE BLVD., BRIDGEWATER NJ 08807
Sam Eldessouky officer: EVP & Chief Financial Officer C/O BLCO, 400 SOMERSET CORPORATE BLVD., BRIDGEWATER NJ 08807
Steven D Miller director 16690 COLLINS AVENUE, PH, SUNNY ISLE BEACH FL 33160
Von Eschenbach Andrew C. director C/O BLCO, 400 SOMERSET CORPORATE BLVD., BRIDGEWATER NJ 08807
De Schutter Richard U director C/O BLCO, 400 SOMERSET CORPORATE BLVD., BRIDGEWATER NJ 08807
Brett Icahn director C/O ICAHN ENTERPRISES L.P., 16690 COLLINS AVE., PH, SUNNY ISLES FL 33160
William D. Humphries officer: EVP, COMPANY GROUP CHAIRMAN C/O STRATA SKIN SCIENCES, INC., 5 WALNUT GROVE DRIVE SUITE 140, HORSHAM PA 19044
Valueact Capital Master Fund, L.p. director, other: See remarks ONE LETTERMAN DRIVE, BUILDING D, 4TH FLOOR, SAN FRANCISCO CA 94129

Bausch Health (Bausch Health) Headlines